Works matching IS 01615505 AND DT 2022 AND VI 63 AND IP 8

Results: 9

SIR-Spheres® activity measurements reveal systematic miscalibration.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 122, doi. 10.2967/jnumed.121.262650

By:

Graves, Stephen A.;
Martin, Molly;
Tiwari, Ashok;
Merrick, Michael;
Sunderland, John

Publication type:

Article

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 114, doi. 10.2967/jnumed.121.262622

By:

Westdorp, Harm;
Verhoeff, Sarah R.;
Gotthardt, Martin;
van Herpen, Carla M. L.;
van den Heuvel, Michel M.;
Heskamp, Sandra;
Aarntzen, Erik H. J. G.

Publication type:

Article

Prognostic value of Urokinase-type Plasminogen Activator Receptor (uPAR)-PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18F-FDG-PET/CT: A single-center prospective study.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262866

By:

Risør, Louise M.;
Clausen, Malene M.;
Ujmajuridze, Zaza;
Farhadi, Mohammed;
Andersen, Kim F.;
Loft, Annika;
Friborg, Jeppe;
Kjaer, Andreas

Publication type:

Article

18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy .

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262854

By:

Messerschmidt, Konstantin;
Barthel, Henryk;
Brendel, Matthias;
Scherlach, C.;
Hoffmann, K.-T.;
Rauchmann, B. S.;
Rullmann, M.;
Marek, K.;
Villemagne, V. L.;
Rumpf, J.-J.;
Saur, D.;
Schroeter, M. L.;
Schildan, A.;
Patt, M.;
Beyer, L.;
Song, M.;
Palleis, C.;
Katzdobler, S.;
Fietzek, U. M.;
Respondek, G.

Publication type:

Article

18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 203, doi. 10.2967/jnumed.121.262861

By:

Ilhan, Harun;
Kroenke, Markus;
Wurzer, Alexander;
Unterrainer, Marcus;
Heck, Matthias;
Belka, Claus;
Knorr, Karina;
Langbein, Thomas;
Rauscher, Isabel;
Schmidt-Hegemann, Nina-Sophie;
Schiller, Kilian;
Bartenstein, Peter;
Wester, Hans-Jürgen;
Eiber, Matthias

Publication type:

Article

SIGNALING PATHWAYS THAT DRIVE 18F-FDG ACCUMULATION IN CANCER.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 95, doi. 10.2967/jnumed.121.262609

By:

Salas, Jessica R.;
Clark, Peter M.

Publication type:

Article

Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of 89Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262485

By:

Farwell, Michael D.;
Gamache, Raymond F.;
Babazada, Hasan;
Hellmann, Matthew D.;
Harding, James J.;
Korn, Ron;
Mascioni, Alessandro;
Le, William;
Wilson, Ian;
Gordon, Michael S.;
Wu, Anna M.;
Ulaner, Gary A.;
Wolchok, Jedd D.;
Postow, Michael A.;
Pandit-Taskar, Neeta

Publication type:

Article

Alzheimer’s disease – standard of diagnosis, treatment, care, and prevention.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 30, doi. 10.2967/jnumed.121.262239

By:

Teipel, Stefan;
Gustafson, Deborah;
Ossenkoppele, Rik;
Hansson, Oskar;
Babiloni, Claudio;
Wagner, Michael;
Riedel-Heller, Steffi G.;
Kilimann, Ingo;
Yi Tang

Publication type:

Article

Fluorescent molecular imaging can improve intraoperative sentinel margin detection in oral squamous cell carcinoma.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262235

By:

Krishnan, Giri;
van den Berg, Nynke S.;
Naoki Nishio;
Kapoor, Shrey;
Pei, Jaqueline;
Freeman, Laura;
Yu-Jin Lee;
van Keulen, Stan;
Farkurnejad, Shayan;
Condon, James;
Baik, Fred M.;
Martin, Brock A.;
Rosenthal, Eben L.

Publication type:

Article

Works matching IS 01615505 AND DT 2022 AND VI 63 AND IP 8

SIR-Spheres<sup>®</sup> activity measurements reveal systematic miscalibration.

Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.

Prognostic value of Urokinase-type Plasminogen Activator Receptor (uPAR)-PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with <sup>18</sup>F-FDG-PET/CT: A single-center prospective study.

18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy .

<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study.

SIGNALING PATHWAYS THAT DRIVE 18F-FDG ACCUMULATION IN CANCER.

Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

Alzheimer’s disease – standard of diagnosis, treatment, care, and prevention.

Fluorescent molecular imaging can improve intraoperative sentinel margin detection in oral squamous cell carcinoma.